Impacting Public Health Response to COVID-19 Through Genome Sequencing
Adam Lauring, MD, PhD leads two studies utilizing genome sequencing to help determine how the virus’s behavior changes from one person to the next and how it transmits.
Adam Lauring, MD, PhD leads two studies utilizing genome sequencing to help determine how the virus’s behavior changes from one person to the next and how it transmits.
Nicole Bhave, MD reminds patients that the Emergency Department is still the safest place to be when you’re having a cardiovascular emergency.
Ray Zuo, MD; Yogen Kanthi, MD; and Jason Knight, MD, PhD find a connection between destructive white blood cells and a more severe disease course in patients with COVID-19.
Lona Mody, MD, MSc and team find that nursing homes in Michigan that responded to a survey were far better prepared for this pandemic than they were for the last one.
Susan Goold, MD discusses the guidelines she helped to develop for the ethical allocation of scarce resources during a public health emergency and how she hopes nobody will need to use them.
David Ginsburg, MD and Brian Emmer, MD, PhD lead team in utilizing CRISPR technology to identify novel genetic interactions relevant to the COVID-19 viral infection.
Division of Pulmonary & Critical Care Medicine researchers are developing new innovations and leveraging existing research projects to care for those impacted by the pandemic.
Daniel Kaul, MD and Kevin Gregg, MD lead clinical trials to determine whether Remdesivir and Sarilumab could be safe and effective treatments for patients with COVID-19.
Scott Flanders, MD comments on the significance of the MI-COVID19 registry that is being coordinated through the Michigan Hospital Medicine Safety Consortium.
Valerie Vaughn, MD, MSc shares her experience and thoughts as she continues the fight against COVID-19.
Goutham Narla, MD, PhD discusses his recent research that identified the binding pocket for molecules that can stabilize a key braking mechanism in cancer.
Marisa Miceli, MD and Peter Higgins, MD, PhD, MSc lead study that focuses on how effective Hydroxychloroquine may be in protecting health care providers.
Jacob Kurlander, MD, MS finds that efforts to reduce PPI use may have had the unintended consequence of health care providers discontinuing them in situations where they were necessary.
Vineet Chopra, MD, MSc discusses the current status of COVID-19 and answers the latest frequently asked questions in an Instagram Live chat.
Matthias Kretzler, MD and team investigate factors that increase virus receptors on cells and whether existing medications could make the receptors less susceptible to viral damage.
Deborah Levine, MD, MPH finds that black individuals’ higher cumulative blood pressure levels may contribute to racial differences in later-life cognitive decline.
William Chey, MD discusses the recent ranitidine recall and offers tips for treating the condition now that Zantac is no longer an option.
Beth Wallace, MD, MSc selected to lead the recently created COVID-19 Global Rheumatology Alliance Registry for the region.
Scott Soleimanpour, MD shares what’s currently known about diabetes and the coronavirus, as well as how to prepare and cope.
The U-M Center for Drug Repurposing, co-led by Jonny Sexton, PhD, mobilizes its resources to identify and screen drugs most likely to be effective as therapeutic interventions for COVID-19.